State-of-the-Art Neonatal Medicine in Japan
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 503
Special Issue Editor
Interests: bronchopulmonary dysplasia; patent ductus arteriosus; preterm infants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In conjunction with the significant advancements in perinatal and neonatal medicine, there has been a notable decline in global rates of neonatal and infant mortality. Japan boasts one of the lowest rates of neonatal and infant mortality in the world. In particular, the results for extremely premature babies and periviable babies born at 22–23 weeks of gestation are exemplary. Japanese neonatal medicine and neonatology have recently gained global recognition. In light of these developments, we have created this Special Issue, which will focus on the cutting-edge neonatal medicine currently being carried out in Japan.
We invite all authors who are actively involved in neonatal medicine in Japan to contribute to this Special Issue. We welcome original research articles and reviews on the most pressing topics related to identifying and introducing new medicines and cutting-edge methodological advances.
Dr. Fumihiko Namba
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesenchymal stromal cells
- artificial placenta
- therapeutic gasses
- animal models
- off-label drug use
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
